Capri Global Capital Ltd. moves to reshape its capital structure

Projected all-in cost: approximately 10.4%, using the reported 7.75% dollar-note pricing plus an indicative 2.65% one-year currency-hedging cost. This is a derived proxy, not a confirmed transaction cost: the hedging input is one-year and the issue tenor was reported as 3 years and 3 months. ^{[1] [2]}

Against CGCL’s reported 9.1% weighted average cost of domestic borrowings for Q1 FY27, the proxy all-in foreign-currency cost is approximately 1.3 percentage points higher, rather than cheaper. ^[1]

For a USD 30 million issuance, that equates to an indicative annual funding cost of about USD 3.12 million, before issuance fees, taxes, and any difference between the one-year hedge cost and the actual hedge cost over the bond’s full tenor. The company’s regulatory approval confirms the proposed USD 30 million issuance, but does not disclose the final coupon or hedge pricing. ^[3]

Key caveat: the precise all-in cost cannot be confirmed from the disclosed terms because CGCL has not quantified the mandatory hedge premium or amortised issuance expenses. If the final coupon is the subsequently reported 7.55%, the same 2.65% hedge proxy would imply 10.20%, still about 1.1 pp above the 9.1% domestic borrowing cost. ^[4]

The specific end use of the USD 30 million proceeds could not be confirmed from the cited approval. The filing only records approval for up to 3,000 senior, secured, rated, listed and redeemable USD-denominated bonds of USD 10,000 each, aggregating up to USD 30 million; it contains no proceeds-allocation or end-use clause in the cited passage. ^[3]

Accordingly:

• Foreign-currency on-lending: not confirmed.
• General corporate purposes under the ECB framework: not confirmed.
• What is established: this is a proposed USD-denominated bond issuance approved by NSE IFSC; the approval itself does not establish how the proceeds will be deployed. ^[3]

The denomination of the borrowing in USD should not, by itself, be interpreted as a mandate to lend onward in foreign currency. A definitive conclusion would require the final offering document, ECB filing, or a subsequent company disclosure specifying the permitted end use.

Verdict: The NSE IFSC transaction is best viewed as a third funding leg alongside domestic bank loans and domestic NCDs, rather than a replacement for either. Its main strategic contribution is lender-base diversification: it opens access to overseas institutional bond investors and non-bank pools, reducing reliance on domestic banks and domestic capital-market liquidity. However, it also introduces USD/INR hedging exposure and collateral encumbrance.

How the funding mix broadens

The completed maiden USD bond transaction was reported at USUSD 300 million, with 49% allocated to US investors, 39% to Asia and 12% to EMEA. By investor type, asset and fund managers accounted for 91%, insurers 5% and banks, private banks and others 4% ^[4]. The notes were issued under Regulation S and Rule 144A, and listed on India International Exchange IFSC and NSE IFSC, reinforcing that this was designed to access an international institutional market rather than simply repackage a domestic NCD ^[5].

That is a meaningful distinction from bank loans: the new investors are predominantly non-bank institutional creditors, while the geographic distribution is outside the company’s domestic funding base. Against domestic NCDs, the diversification is less about instrument type—the USD notes are also debt securities—and more about investor geography, currency and distribution channel.

Liability-management implications

• Reduced single-channel dependence: The transaction gives Capri Global another funding route if domestic bank appetite or Indian NCD pricing becomes less favourable. The company’s investor presentation frames diversification of borrowings as a funding objective ^[6].
• Potentially stronger funding access: The issue reportedly attracted demand exceeding USUSD 700 million, or over 2.3 times the issue size, indicating initial acceptance among global institutional investors ^[7]. This could help establish repeat access under the company’s USUSD 1 billion global medium-term note programme ^[5].
• Cost comparison is not simply 7.55% versus domestic borrowing: The reported 7.55% fixed coupon ^[4] must be adjusted for INR/USD hedging and issuance costs. Domestic borrowing cost was reported at 9.1% for Q1 FY27, but the all-in INR cost of the dollar notes could not be confirmed because the hedge premium and amortised issuance expenses were not quantified ^[1].
• Collateral trade-off: The notes are senior secured, with a first-ranking pari-passu charge over identified receivables ^[8]. This improves creditor protection and may support market access, but it also consumes collateral that could otherwise support future secured borrowing.

One disclosure limitation is important: the exact recent percentage split between domestic NCDs and bank loans is not available in the cited extracts. Therefore, the transaction clearly broadens the funding architecture, but its precise effect on concentration cannot be quantified from the reported mix. Also, one regulatory disclosure refers to approval for up to USUSD 30 million ^[3], while separate September disclosures describe the completed USUSD 300 million maiden issue ^[4]. Those amounts should be reconciled before treating them as the same tranche.